Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine vs midazolam as premedication for pediatric sedation and parent-child separation
IRCT2016082411766N4Phase 3Completed
- Sponsor
- Vice chancellor of Research of Guilan University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine and midazolam in Social Anxiety Disorder (SAD) (2 arms), sponsored by Vice chancellor of Research of Guilan University of Medical Sciences. Primary endpoints: Sedation effectiveness and Ease of separation from parents. Started Oct 2016; status: completed.
02
Drugs
ketaminemidazolam
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on IRCT2016082411766N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016082411766N4.